Publications
- RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS2022 | First Faculty of Medicine, Faculty of Science
- Aging-Related Gene Expression Signatures Define Likelihood of Disease Progression in Patients with Lower-Risk Myelodysplastic SyndromesPublication without faculty affiliation
- Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms2024 | First Faculty of Medicine, Faculty of Science, Faculty of Physical Education and Sport
- ABC transporters are predictors of treatment failure in acute myeloid leukaemia2024 | First Faculty of Medicine, Faculty of Science
- Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B12023 | Central Library of Charles University, Faculty of Science
- Klinický význam rozsahu del(5q) u nemocných s MDS2021 | First Faculty of Medicine, Central Library of Charles University
- DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population2013 | First Faculty of Medicine
- Upregulation of ZEB1-Derived Circular RNAs Is Associated with SF3B1-Mutated Myelodysplastic NeoplasmsPublication without faculty affiliation
- SF3B1 mutations and their impact on cellular bioenergetics in myelodysplastic syndromesPublication without faculty affiliation
- Hematopoietic stem cells of lower-risk MDS patients with rapid progression show quiescent-like cell state similar to that of higher-risk MDS cellsPublication without faculty affiliation
Loading network view...